We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca Submits Applications to Expand Nexium Franchise
AstraZeneca Submits Applications to Expand Nexium Franchise
May 8, 2009
AstraZeneca has submitted an NDA to the FDA for a product that would allow patients to take low-dose aspirin with a lower risk of gastric or duodenal ulcers.